These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 21887406

  • 21. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
    Darmoul D, Gratio V, Devaud H, Peiretti F, Laburthe M.
    Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
    [Abstract] [Full Text] [Related]

  • 22. Tyrphostin AG825 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2.
    Murillo H, Schmidt LJ, Tindall DJ.
    Cancer Res; 2001 Oct 15; 61(20):7408-12. PubMed ID: 11606371
    [Abstract] [Full Text] [Related]

  • 23. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
    Cunningham MP, Thomas H, Marks C, Green M, Fan Z, Modjtahedi H.
    Int J Oncol; 2008 Nov 15; 33(5):1107-13. PubMed ID: 18949375
    [Abstract] [Full Text] [Related]

  • 24. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
    Banudevi S, Senthilkumar K, Sharmila G, Arunkumar R, Vijayababu MR, Arunakaran J.
    Clin Chim Acta; 2010 Feb 15; 411(3-4):172-8. PubMed ID: 19913001
    [Abstract] [Full Text] [Related]

  • 25. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH, Song YC, Kim SH, Jo H, Song YS.
    Ann N Y Acad Sci; 2009 Aug 15; 1171():642-8. PubMed ID: 19723115
    [Abstract] [Full Text] [Related]

  • 26. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S, Bergelin N, Löf C, Vainio M, Andersson S, Törnquist K.
    Endocr Relat Cancer; 2008 Jun 15; 15(2):521-34. PubMed ID: 18509004
    [Abstract] [Full Text] [Related]

  • 27. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
    Recchia AG, Musti AM, Lanzino M, Panno ML, Turano E, Zumpano R, Belfiore A, Andò S, Maggiolini M.
    Int J Biochem Cell Biol; 2009 Mar 15; 41(3):603-14. PubMed ID: 18692155
    [Abstract] [Full Text] [Related]

  • 28. Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma.
    Hagan M, Yacoub A, Dent P.
    Clin Cancer Res; 2004 Sep 01; 10(17):5724-31. PubMed ID: 15355899
    [Abstract] [Full Text] [Related]

  • 29. Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands.
    Carrión-Salip D, Panosa C, Menendez JA, Puig T, Oliveras G, Pandiella A, De Llorens R, Massaguer A.
    Int J Oncol; 2012 Sep 01; 41(3):1128-38. PubMed ID: 22684500
    [Abstract] [Full Text] [Related]

  • 30. EGF-Induced VEGF Exerts a PI3K-Dependent Positive Feedback on ERK and AKT through VEGFR2 in Hematological In Vitro Models.
    Saryeddine L, Zibara K, Kassem N, Badran B, El-Zein N.
    PLoS One; 2016 Sep 01; 11(11):e0165876. PubMed ID: 27806094
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Signaling mechanisms that mediate invasion in prostate cancer cells.
    Bonaccorsi L, Marchiani S, Muratori M, Carloni V, Forti G, Baldi E.
    Ann N Y Acad Sci; 2004 Dec 01; 1028():283-8. PubMed ID: 15650253
    [Abstract] [Full Text] [Related]

  • 33. Silibinin impairs constitutively active TGFalpha-EGFR autocrine loop in advanced human prostate carcinoma cells.
    Tyagi A, Sharma Y, Agarwal C, Agarwal R.
    Pharm Res; 2008 Sep 01; 25(9):2143-50. PubMed ID: 18253818
    [Abstract] [Full Text] [Related]

  • 34. δ-Tocopherol inhibits receptor tyrosine kinase-induced AKT activation in prostate cancer cells.
    Wang H, Hong J, Yang CS.
    Mol Carcinog; 2016 Nov 01; 55(11):1728-1738. PubMed ID: 26465359
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. EGFR-SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors.
    Ren J, Bollu LR, Su F, Gao G, Xu L, Huang WC, Hung MC, Weihua Z.
    Prostate; 2013 Sep 01; 73(13):1453-61. PubMed ID: 23765757
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.